Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 23,959 $ 8,408
Restricted cash 250
Marketable debt securities, available for sale 3,539 8,779
Marketable equity securities, at fair value 76
Accounts receivable, net 36,670 37,708
Inventory, net 4,509 4,600
Prepaid expenses and other current assets 1,598 1,496
Total current assets 70,275 61,317
Property, plant and equipment, net 6,252 5,947
Prepaid expenses, net of current portion 167 460
Operating lease right-of-use asset, net 4,234 4,402
Intangible assets, net 9,434 10,852
Goodwill 5,709 5,709
Deferred tax asset 594
Other assets 1,282 608
TOTAL ASSETS 97,947 89,295
Current liabilities    
Accounts payable 4,445 7,026
Accrued diagnostic services 760 1,890
Accrued advertising and other allowances 155 104
Operating lease liabilities 628 663
Deferred revenue 2,430 2,034
Income tax payable 6,787 1,312
Other current liabilities 1,517 2,495
Total current liabilities 16,722 15,524
Non-current liabilities:    
Deferred revenue, net of current portion 983 905
Note payable 44
Unsecured convertible promissory notes, net 7,998 9,996
Operating lease liabilities, net of current portion 4,086 4,198
Total non-current liabilities 13,067 15,143
Total liabilities 29,789 30,667
COMMITMENTS AND CONTINGENCIES  
Stockholders’ equity    
Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding
Common stock authorized 50,000,000, $0.0005 par value, 15,722,827 and 15,485,900 shares outstanding, respectively 16 16
Additional paid-in capital 106,162 104,552
Retained earnings 13,231 2,642
Treasury stock, at cost, 17,352,419 and 16,818,846 shares, respectively (51,015) (48,407)
Accumulated other comprehensive loss (236) (175)
Total stockholders’ equity 68,158 58,628
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 97,947 $ 89,295